Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02132104Unknown
Randomised, open-label trial (2 arms), sponsored by Capital Medical University. Primary endpoint: Safety of intrauterine application of amnion membrane at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02132104.